Product Details

Voltaren

Diclofenac Sodium
25 mg
Enteric Coated Tablet


DIN/PIN/NPN

00514004

Manufacturer

Geigy Pharmaceuticals,Division of Ciba-Geigy Canada Ltd.

Formulary Listing Date

1996-10-01  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Not a Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Diclofenac Sodium 25 mg Enteric-Coated Tablet: NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.

ATC Code

M01AB05

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
00514004 Voltaren NA NA
00808539 Teva-Diclofenac 0.0781 0.0781
02302616 PMS-Diclofenac 0.0781 0.0781
00839175 Apo-Diclo 0.0781 0.0781
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph